To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
Status:
Withdrawn
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This will be a multi-center, randomized, double-blind, placebo-controlled, crossover study to
evaluate the effects of 2007/Fycompa (perampanel) on sleep, in subjects with well controlled
partial onset seizures (on an antiepileptic drug [AED] monotherapy) who are experiencing
sleep onset insomnia.